Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical and clinical compositions of desAA fibrin monomers and the tetrapeptide gly-pro-arg-pro

Pharmaceutical and clinical compositions of desAA fibrin monomers and the tetrapeptide gly-pro-arg-pro

US Patent 4957903 · Granted Sep 18, 1990

Estimated economic value: $72,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Assay to determine anticoagulants in blood or blood plasma2020
System for enabling test data from a clinical analytic device to be communicated2017
Hematocrit and analyte concentration determination2014
Surface plasmon apparatus2012
Sensor unit for a surface plasmon resonance (SPR) unit2012
Anti-coagulation of blood, plasma or synovial fluid products using iso-citrate2002
Method for analysis of haemostatic activity2000
Method of performing tissue plasminogen activator assay1992
Assays for plasminogen activator inhibitor and soluble fibrin1992
Solid phase reactant for inhibition and removal of serine proteases and method o1991